Tevogen Logo Notified.png
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
October 18, 2024 22:46 ET | Tevogen Bio Inc
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
October 18, 2024 18:00 ET | Celularity Inc.
FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies,...
GMLOGO_2024_rgb_high.png
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
October 18, 2024 16:30 ET | Globus Medical
AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma...
Rally House College Park Storefront
Rally House Opens in College Park, Maryland
October 18, 2024 14:35 ET | Rally House
Rally House announces the opening of their first store to open in the Maryland market with Rally House College Park.
BFRG logo.png
Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
October 18, 2024 09:30 ET | BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial...
Peter MD Logo.png
Revolutionizing Health Optimization: Peter MD Announces Major Rebrand and Industry-Changing Mobile App
October 18, 2024 09:00 ET | Peter MD
Vero Beach, Florida, Oct. 18, 2024 (GLOBE NEWSWIRE) -- In response to exponential growth and overwhelming patient demand, Peter MD, the nation’s leading online hormone replacement therapy (HRT)...
thedartlogo.png
The Dart Co. Introduces New Microdosing Device and Resource Center
October 18, 2024 09:00 ET | The Dart Co
Los Angeles, CA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The Dart Co., known for its innovative smoking pipes and accessories, is proud to announce the launch of the Dart MD, a cutting-edge device...
SeaStar_SM_LogoCard.png
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
October 18, 2024 08:30 ET | SeaStar Medical Holding Corporation
The pace of patient enrollment has significantly accelerated following a summertime slowdown DENVER, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a...
Arcutis logo.png
Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
October 18, 2024 08:20 ET | Arcutis Biotherapeutics, Inc.
Arcutis today announced regulatory approval from Health Canada for ZORYVE (roflumilast) topical foam 0.3% for the treatment of seborrheic dermatitis.
Figure 1
Calibre Announces Q3 & Year to Date 2024 Gold Production; Revises 2024 Guidance With Q4 Expected to Be the Strongest Production of the Year; Valentine Remains Fully Funded and On Track for Q2, 2025 Gold Production
October 18, 2024 06:00 ET | Calibre Mining Corp.
VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the "Company" or "Calibre") announces operating results for the three months (“Q3”) and...